These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8752627)

  • 1. Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin.
    Phipps WR; Holden D; Sheehan RK
    Fertil Steril; 1996 Jul; 66(1):148-50. PubMed ID: 8752627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization.
    Hull MG; Armatage RJ; McDermott A
    Fertil Steril; 1994 Nov; 62(5):997-1003. PubMed ID: 7926148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant Human FSH Study Group.
    Fertil Steril; 1995 Jan; 63(1):77-86. PubMed ID: 7805928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follitropin alpha in infertility: a review.
    Goa KL; Wagstaff AJ
    BioDrugs; 1998 Mar; 9(3):235-60. PubMed ID: 18020563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle.
    BioDrugs; 2003; 17(4):288-9. PubMed ID: 12899646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of recombinant follicle stimulating hormone in a woman with allergic reaction to menotropin: a case report.
    Harrison S; Wolf T; Abuzeid MI
    Gynecol Endocrinol; 2000 Jun; 14(3):149-52. PubMed ID: 10923273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization.
    Commenges-Ducos M; Piault S; Papaxanthos A; Ribes C; Dallay D; Commenges D
    Fertil Steril; 2002 Nov; 78(5):1049-54. PubMed ID: 12413992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
    Aboulghar M; Saber W; Amin Y; Aboulghar M; Mansour R; Serour G
    Fertil Steril; 2010 Nov; 94(6):2332-4. PubMed ID: 20188364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
    de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
    Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer.
    Brinsden P; Akagbosu F; Gibbons LM; Lancaster S; Gourdon D; Engrand P; Loumaye E
    Fertil Steril; 2000 Jan; 73(1):114-6. PubMed ID: 10632423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.
    Selman HA; De Santo M; Sterzik K; Coccia E; El-Danasouri I
    Fertil Steril; 2002 Nov; 78(5):1061-7. PubMed ID: 12413994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
    Surrey ES; Bower J; Hill DM; Ramsey J; Surrey MW
    Fertil Steril; 1998 Mar; 69(3):419-24. PubMed ID: 9531870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study.
    Tulppala M; Aho M; Tuuri T; Vilska S; Foudila T; Hakala-Ala-Pietilä T; Moilanen J; Bützow T; Kaukoranta S; Söderström-Anttila V; Siegberg R; Suikkari AM; Hovatta O
    Hum Reprod; 1999 Nov; 14(11):2709-15. PubMed ID: 10548606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
    Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
    Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization.
    Sills ES; Levy DP; Moomjy M; McGee M; Rosenwaks Z
    Hum Reprod; 1999 Sep; 14(9):2230-5. PubMed ID: 10469685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.